# Valproic Acid

## Depakin inj 400mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IDEP4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 適應症     | Absence seizure, Simple and complex. Complex partial epileptic seizure.Manic bipolar I disorder.Migraine; Prophylaxis.Seizure, Multiple seizure types.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 用法用量   | Seizures unable to use oral form valproic acid: Total daily IV dose should be equivalent to the total daily oral valproate dose (expressed as valproic acid) and divided every 6 hours. Administer each dose as a 60-minute infusion (rate ?20 mg/minute). Start intravenous administration 4 to 6 hours after the last oral administration. The original oral dose (usually an average dose of 20 to 30 mg/kg/day) can be administered by drip for 24 hours. To achieve therapeutic levels of valproic acid quickly: initially give 15 mg/kg by a slow intravenous injection (> 5 minutes), followed by 1 mg/kg/hour intravenous continuous infusion, and adjust the dose according to target serum level and clinical symptoms.                                                                                                                                                                                                                                                                                                      |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌       | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 副作用     | Cardiovascular: Peripheral edema (3% to 8% ) Dermatologic: Alopecia (6% to 24% ), Rash (6% ) Endocrine metabolic: Increased appetite (6% ), Weight increased (4% to 9% ) Gastrointestinal: Abdominal pain (9% to 23% ), Constipation (5% ), Diarrhea (12% to 23% ), Indigestion (8% to 13% ), Loss of appetite (4% to 12% ), Nausea (22% to 48% ), Vomiting (11% to 27% ) Hematologic: Ecchymosis (4% to 5% ) Musculoskeletal: Asthenia (10% to 27% ), Backache (8% ) Neurologic: Amnesia (4% to 7% ), Ataxia (8% ), Dizziness (12% to 25% ), Headache (5% to 31% ), Insomnia (9% to 15% ), Somnolence (17% to 30% ), Tremor (9% to 57% ) Ophthalmic: Amblyopia, Blurred vision, Diplopia (16% ), Nystagmus (1% to 8% ) Otic: Tinnitus (1% to 7% ) Psychiatric: Depression (4% to 5% ), Disturbance in thinking (6% ), Feeling nervous (7% to 11% ), Mood swings (6% ) Respiratory: Bronchitis (5% ), Dyspnea (5% ), Pharyngitis (8% ), Respiratory tract infection (12% to 20% ), Rhinitis (5% ) Other: Fever (2% ), Influenza (12% ) |
| 孕期建議   | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

## Depakin solution 200mg/mL， 40mL

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | LDEP                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 適應症     | Epilepsy particularly of grand mal combined with petit mal & myoclonic petit mal types.                                                                                                                                                                                                                                                                                                                              |
| 用法用量   | Giving with food to decrease gastrointestinal irritation. Children 6 years and below: syrup or oral liquid is recommended for administration. DEPAKINE 500mg Chrono Tablet is only recommended for adult and children > 17 kg. Average daily dose (per 24 hours): Adult and adolescents: 20-30 mg/kg/day in 2 or 3 divided doses. Children: 30 mg/kg/day in 2 or 3 divided doses. (< 1 year old: in 2 divided doses) |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                         |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                         |
| 禁忌       | Acute or chronic hepatitis, personal or family history of severe hepatitis, hepatic porphyria.                                                                                                                                                                                                                                                                                                                       |
| 副作用     | GI disturbances, ataxia, tremor, increased appetite & weight gain, edema, thrombocytopenia, inhibition of platelet aggregation; impaired hepatic function, rashes, sedation. Rarely, pancreatitis (discontinue).                                                                                                                                                                                                     |
| 孕期建議   | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                 |

## Depakine 200mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | ODEP2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 適應症     | 主治癲癇、及情緒穩定劑(B014899100) Treatment of generalized or partial epilepsy; mania.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 用法用量   | Giving with food to decrease gastrointestinal irritation. Children 6 years and below: syrup or oral liquid is recommended for administration. DEPAKINE 500mg Chrono Tablet is only recommended for adult and children > 17 kg. Average daily dose (per 24 hours): Adult and adolescents: 20-30 mg/kg/day in 2 or 3 divided doses. Children: 30 mg/kg/day in 2 or 3 divided doses. (< 1 year old: in 2 divided doses)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 禁忌       | Acute or chronic hepatitis, personal or family history of severe hepatitis, hepatic porphyria. Combination with mefloquine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 副作用     | GI disturbances, ataxia, tremor, increased appetite & weight gain, edema, thrombocytopenia, inhibition of platelet aggregation; impaired hepatic function, rashes, sedation. Rarely, pancreatitis (discontinue). Cardiovascular: Peripheral edema (3% to 8% ) Dermatologic: Alopecia (6% to 24% ), Rash (6% ) Endocrine metabolic: Increased appetite (6% ), Weight increased (4% to 9% ) Gastrointestinal: Abdominal pain (9% to 23% ), Constipation (5% ), Diarrhea (12% to 23% ), Indigestion (8% to 13% ), Loss of appetite (4% to 12% ), Nausea (22% to 48% ), Vomiting (11% to 27% ) Hematologic: Ecchymosis (4% to 5% ) Musculoskeletal: Asthenia (10% to 27% ), Backache (8% ) Neurologic: Amnesia (4% to 7% ), Ataxia (8% ), Dizziness (12% to 25% ), Headache (5% to 31% ), Insomnia (9% to 15% ), Somnolence (17% to 30% ), Tremor (9% to 57% ) Ophthalmic: Amblyopia, Blurred vision, Diplopia (16% ), Nystagmus (1% to 8% ) Otic: Tinnitus (1% to 7% ) Psychiatric: Depression (4% to 5% ), Disturbance in thinking (6% ), Feeling nervous (7% to 11% ), Mood swings (6% ) Respiratory: Bronchitis (5% ), Dyspnea (5% ), Pharyngitis (8% ), Respiratory tract infection (12% to 20% ), Rhinitis (5% ) Other: Fever (2% ), Influenza (12% ) |
| 孕期建議   | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## DEPAKINE 500mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | ODEP5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 適應症     | 主治癲癇、及情緒穩定劑(B014899100) Treatment of generalized or partial epilepsy; mania.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 用法用量   | Epilepsy: Adult and children > 17 kg: Initially 10-15 mg/kg/day ,then increase to the appropriate dose: 20-30 mg/kg/day in 1-2 divided doses. When epilepsy is not controlled or side effects are suspected, the blood concentration of valproic acid can be used for clinical follow-up. The effective therapeutic concentration is usually between 40-100 mg/L (280 to 700 μmol/L). Mania: Initially 600 mg daily increasing by 200 mg/day every 3 days to reach desired clinical effect. Usual dose range: 1000-2000 mg/day (20-30 mg/kg/day) Dose may be further increased to maximum 2500 mg/day if necessary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 禁忌       | Acute or chronic hepatitis, personal or family history of severe hepatitis, hepatic porphyria. Combination with mefloquine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 副作用     | GI disturbances, ataxia, tremor, increased appetite & weight gain, edema, thrombocytopenia, inhibition of platelet aggregation; impaired hepatic function, rashes, sedation. Rarely, pancreatitis (discontinue). Cardiovascular: Peripheral edema (3% to 8% ) Dermatologic: Alopecia (6% to 24% ), Rash (6% ) Endocrine metabolic: Increased appetite (6% ), Weight increased (4% to 9% ) Gastrointestinal: Abdominal pain (9% to 23% ), Constipation (5% ), Diarrhea (12% to 23% ), Indigestion (8% to 13% ), Loss of appetite (4% to 12% ), Nausea (22% to 48% ), Vomiting (11% to 27% ) Hematologic: Ecchymosis (4% to 5% ) Musculoskeletal: Asthenia (10% to 27% ), Backache (8% ) Neurologic: Amnesia (4% to 7% ), Ataxia (8% ), Dizziness (12% to 25% ), Headache (5% to 31% ), Insomnia (9% to 15% ), Somnolence (17% to 30% ), Tremor (9% to 57% ) Ophthalmic: Amblyopia, Blurred vision, Diplopia (16% ), Nystagmus (1% to 8% ) Otic: Tinnitus (1% to 7% ) Psychiatric: Depression (4% to 5% ), Disturbance in thinking (6% ), Feeling nervous (7% to 11% ), Mood swings (6% ) Respiratory: Bronchitis (5% ), Dyspnea (5% ), Pharyngitis (8% ), Respiratory tract infection (12% to 20% ), Rhinitis (5% ) Other: Fever (2% ), Influenza (12% ) |
| 孕期建議   | Human (and animal) data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

